Purchase this article with an account.
M. Li, J. E. Lee, H. Choi, H. Park, J. Jung; Clinical Outcomes of Secondary Iol Implantation in Aphakic Vitrectomized Eyes. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5739.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Vitrectomized eyes are challenging to implant intraocular lens (IOL) secondarily. The clinical outcomes of IOL implantation in aphakic vitrectomized eyes were evaluated
Medical records of 43 patients who had transscleral fixation of an IOL in the aphakic and vitrectomized eye were reviewed retrospectively. To maintain intraocular pressure during the operation, a cannula was placed at the pars plana infusing balanced salt solution. The IOL was inserted through the sclera tunnel incision, and the haptics were fixed by suturing at the ciliary sulcus. Pre- and postoperative best-corrected visual acuity (BCVA), and difference between target and postoperative refractive error were analyzed
Mean age of the patients was 45.6 years. Mean follow-up was 11.9 ± 11.6 months. The underlying vitreoretinal disease were ocular trauma (n=33), rhegmatous retinal detachment (n=3), complicated cataract surgery (n=2), uveitis (n=2), congenital cataract (n=1), acute retinal necrosis (n=1), and secondary glaucoma (n=1). BCVA of logMAR 0.82 at baseline improved to logMAR 0.66 at final visit. Astigmatism was -2.55D preoperatively, and changed into -2.18D, -2.17D, and -1.95D at postoperative 1, 2, and 3 month respectively. Mean postoperative spherical equivalent(SE) was 0.21±5.96D. Mean deviation of final refraction from target refraction was + 0.72±5.90. Postoperative complications included secondary glaucoma (n=1), bullous keratopathy (n=1) and cystoid macular edema (n=1)
Secondary IOL implantation could be performed safely in aphakic vitrectomized eyes. However, primary underlying disease limited visual recovery
This PDF is available to Subscribers Only